Banks are experiencing funding constraints and are adjusting their FY26 growth strategy to focus more on volume expansion instead of margin growth due to a higher reliance on wholesale funding sources. Recent data from the RBI shows that bank advances have grown by 13.8%, surpassing deposit growth at 10.8%. This gap between loans and liabilities is widening, indicating increasing lending activities compared to deposit inflows.

Aurobindo Pharma's latest development, CuraTeQ, reports a successful Phase 3 trial for its BP11 biosimilar, demonstrating similar efficacy to Xolair. The company plans to submit applications for approval by both the EMA and FDA by Q2 2026.

Tata Steel has received a demand of approximately ₹1,755 crore due to alleged overmining of coal at West Bokaro Colliery dating back to FY 2000-07. The company plans to contest the issue legally.

Investment firm Junomoneta Finsol has purchased approximately 750,735 shares in RPSG Ventures at an average price of ₹984.7 each, signifying a significant investment in the company.

Madhucon Projects Ltd has missed loan repayments worth ₹31.4 Crore as of March 31, 2026. The company's overall debt, encompassing both short-term and long-term liabilities, currently stands at ₹143.1 Crore.

Jefferies continues to recommend buying Hindustan Unilever shares, setting a price goal at INR 2,850. The Unilever divestment highlights India's growing strategic significance, but the specific impact on HUL is yet to be clarified.

Equirus, a financial advisory firm, has retained a bullish stance on Lloyds Metals (LMEL), predicting a potential 65% increase to reach ₹2,100 due to its cost efficiency and diversification strategies. However, LMEL's ongoing DRC projects may encounter challenges related to execution, funding, and geopolitical issues, as highlighted by Equirus.

Nomura has raised concerns about margin pressures for oil marketing companies (IOCL, BPCL, HPCL) due to rising prices of ATF and LPG, along with subsidy burdens. On the other hand, Petronet LNG is expanding its capacity to 22.5 mtpa, while Reliance Industries' SEZ refinery has been exempted from windfall tax, boosting their margins.

Patanjali Foods anticipates improved profit margins in their edible oil sector due to escalating prices of palm and soya oil. The potential Indonesian B50 plan, which might decrease palm oil supply, could further reinforce these price hikes.

The Comptroller and Auditor General (CAG) is seeking a penalty of approximately INR 8.49 crores from Bharti Airtel, aiming to recover the sum due to discrepancies in certain accounts.

Navin Chand Suchanti has significantly boosted his stake in Sinclair Hotels Ltd., now holding 63.63%. This increase was made through open market transactions between March 27-30, 2026, elevating the promoter group's ownership.

Astron Paper & Board Mill reached a new 52-week low of ₹3.38 on April 1, 2026, indicating a significant 68.4% drop year over year. Despite some recent positive financial developments, the company continues to face challenges that are affecting its stock performance.

Jubilant FoodWorks has decided to part ways with Dunkin' Donuts due to financial struggles, as the segment accounted for only 0.61% of their revenue and reported a loss of Rs 191 crore. Instead, they are now focusing on their more profitable core business, Domino's Pizza, which is expected to have no significant impact on overall operations.

DCM Shriram Limited has officially launched its complete Ethylene Vinyl Acetate (ECH) plant in Gujarat, expanding the facility's overall production capacity to 52,000 Tons Per Annum (TPA).

Apollo Hospitals boasts a higher Price/Earnings ratio (P/E) than the industry at 59.8, suggesting a strong valuation. Despite short-term fluctuations, its long-term prospects stay positive due to its status as a Nifty 50 component.

Ryan Patel has received 149,900 shares in Patel Engineering Ltd following the passing of Chandrika Patel. This transfer occurs under SEBI's Regulation 10(1)(g), which waives the need for an open offer.

Jubilant Ingrevia has officially taken over Remidex Pharma, securing a full ownership position as per the deal announced on March 13, 2026. This acquisition is expected to strengthen Jubilant Ingrevia's pharmaceutical portfolio significantly.

Oil India and CSIR-IMMT have partnered to research critical minerals essential for advanced industries, marking a strategic move to tap into these valuable resources.

NIBE Ltd's subsidiary, NDAL, is set to be sold to the promoter, Nibe Ganesh Ramesh, by 2026. The transaction will result in NAL no longer being a step-down subsidiary of NIBE Ltd, with completion anticipated by May 30, 2026.